Investment Thesis
While BDX demonstrates solid revenue growth of 8.2% YoY and generates adequate free cash flow of $549M, the company exhibits critical financial anomalies that undermine confidence in reported results. The impossible 144.3% gross margin, stagnant net income despite revenue growth, and severely stressed liquidity metrics (1.05x current ratio, 0.58x quick ratio) combined with negative interest coverage of 0.9x indicate material financial distress or data integrity issues requiring immediate clarification before investment consideration.
BDX Strengths
- Revenue growth of 8.2% YoY demonstrates market demand for medical device/instrumentation products
- Free cash flow generation of $549M provides operational viability despite reported profitability concerns
- Substantial asset base of $54.8B and moderate debt-to-equity ratio of 0.67x indicate reasonable balance sheet foundation
BDX Risks
- Gross margin of 144.3% is financially impossible and suggests either severe data quality issues, consolidation accounting anomalies, or undisclosed liabilities masking true profitability
- Interest coverage ratio of 0.9x indicates inability to cover debt service from operating income, creating refinancing and solvency risk
- Net income stagnation (0% YoY growth) despite 8.2% revenue growth and declining EPS (-0.7% YoY) signals margin compression, operational challenges, or one-time charges
- Quick ratio of 0.58x and current ratio of 1.05x demonstrate tight near-term liquidity with insufficient liquid assets to cover short-term obligations
- 25 Form 4 insider filings in 90 days warrant scrutiny regarding insider sentiment during apparent financial stress
Key Metrics to Watch
- Gross margin reconciliation and explanation of 144% result versus industry norms
- Interest coverage ratio trend and debt service capacity improvements
- Net income and EPS recovery relative to revenue growth rate
- Current and quick ratio trends indicating liquidity trajectory
- Operating cash flow sustainability and working capital management
BDX Financial Metrics
Revenue
$5.3B
Net Income
$382.0M
EPS (Diluted)
$1.34
Free Cash Flow
$549.0M
Total Assets
$54.8B
Cash Position
$740.0M
BDX Profitability Ratios
Gross Margin
144.3%
Operating Margin
10.5%
Net Margin
7.3%
ROE
1.5%
ROA
0.7%
FCF Margin
10.5%
BDX Balance Sheet & Liquidity
Current Ratio
1.05x
Quick Ratio
0.58x
Debt/Equity
0.67x
Debt/Assets
0.0%
Interest Coverage
0.90x
Long-term Debt
$16.9B
Disclaimer: This analysis is generated by Claude AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: Mar 17, 2026 |
Data as of: 2025-12-31 |
Powered by Claude AI